ACE2 and COVID-19: The pathophysiological mechanisms are still not clear; however, the current evidence indicates that the direct effect of the virus on pancreatic β-cells through the angiotensin-converting enzyme-2 (ACE2) receptor [14,37,38] and prolonged inflammation with immune dysregulation [39,40] may be responsible for COVID-19 related diabetes [15].